PGR and non-small cell lung carcinoma: Interestingly, the addition of BR2-PRPPD peptides containing two repeats of the PR-PPD (BR2-2xPPD) was more effective in inhibiting NSCLC proliferation and showed a maximum growth inhibition by 48% (±5%) inhibition.